Maternal and placental ANRIL polymorphisms and preeclampsia susceptibility.

Personalized medicine Pub Date : 2023-09-01 Epub Date: 2023-10-18 DOI:10.2217/pme-2023-0073
Mina Asadi-Tarani, Mohsen Saravani, Marzieh Ghasemi, Mahnaz Rezaei, Saeedeh Salimi
{"title":"Maternal and placental <i>ANRIL</i> polymorphisms and preeclampsia susceptibility.","authors":"Mina Asadi-Tarani,&nbsp;Mohsen Saravani,&nbsp;Marzieh Ghasemi,&nbsp;Mahnaz Rezaei,&nbsp;Saeedeh Salimi","doi":"10.2217/pme-2023-0073","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> The possible effects of maternal and placental <i>ANRIL</i> polymorphisms on preeclampsia were examined. <b>Methods:</b> The maternal blood of 315 preeclamptic and 317 control women and the placentas of 103 preeclamptic and 133 control women were enrolled in the study. <i>ANRIL</i> polymorphisms were genotyped using a PCR-RFLP method. <b>Results:</b> The maternal <i>ANRIL</i> rs1333048C variant showed a relationship with a lower risk of preeclampsia in codominant and dominant models. The maternal <i>ANRIL</i> rs4977574G variant had a relationship with a lower risk of preeclampsia in codominant and recessive models. There was an association between the placental rs1333048C variant and a lower risk of preeclampsia in codominant and dominant models. <b>Conclusion:</b> Maternal <i>ANRIL</i> rs1333048C and rs4977574G variants and placental rs1333048 variant showed a relationship with a lower risk of preeclampsia.</p>","PeriodicalId":94167,"journal":{"name":"Personalized medicine","volume":"20 5","pages":"445-452"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/pme-2023-0073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The possible effects of maternal and placental ANRIL polymorphisms on preeclampsia were examined. Methods: The maternal blood of 315 preeclamptic and 317 control women and the placentas of 103 preeclamptic and 133 control women were enrolled in the study. ANRIL polymorphisms were genotyped using a PCR-RFLP method. Results: The maternal ANRIL rs1333048C variant showed a relationship with a lower risk of preeclampsia in codominant and dominant models. The maternal ANRIL rs4977574G variant had a relationship with a lower risk of preeclampsia in codominant and recessive models. There was an association between the placental rs1333048C variant and a lower risk of preeclampsia in codominant and dominant models. Conclusion: Maternal ANRIL rs1333048C and rs4977574G variants and placental rs1333048 variant showed a relationship with a lower risk of preeclampsia.

母体和胎盘ANRIL多态性与先兆子痫易感性。
目的:探讨母体和胎盘ANRIL多态性对先兆子痫的可能影响。方法:选取315例先兆子痫妇女和317例正常对照妇女的母体血液,103例先兆子痫女性和133例正常对照女性的胎盘进行研究。ANRIL多态性采用PCR-RFLP方法进行基因分型。结果:母体ANRIL rs1333048C变体在共显性和显性模型中显示出与先兆子痫风险较低的关系。在共显性和隐性模型中,母体ANRIL rs4977574G变体与先兆子痫风险较低有关。在共显性和显性模型中,胎盘rs1333048C变体与先兆子痫风险较低之间存在关联。结论:母体ANRIL rs1333048C和rs4977574G变异体以及胎盘rs1333048变异体与先兆子痫的风险较低有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信